• ISHLT Adds Chief Operating Officer and Director, Meetings and Education

    ISHLT is adding professional staff capacity to support the organization's leadership and the transition to the new organizational model. 

    We're excited to announce that Aaron Adair has joined ISHLT as our new Chief Operating Officer and Jacky Schweinzger has joined as our new Director, Meetings and Education. Both have a track record of success and innovation that will support ISHLT’s development. 
  • In Memoriam: David Taylor, ISHLT President 2012-2013

    It is with tremendous sadness that ISHLT recognizes the loss of David Taylor, MD, ISHLT president from 2012 - 2013. Dr. Taylor was a leader in the field of advanced heart failure and transplant cardiology.
  • NEW! Online CME Courses Available to Members Only for $15 per Course

    ISHLT is excited to launch a new initiative for members only: CME credit for select online education courses. These low-cost, easy-to-access courses cover a range of topics, all featuring top specialists who presented at ISHLT2019.

    Earn up to 1.5 credit hours per course!


    Once on the ISHLT Online Education site, click on the Online CME tab to the left.


    Ex-Vivo Lung Perfusion in 2019: From Research to Implementation

    This symposium will bring experts in Ex-Vivo Lung Perfusion and donor lung management from all over the world. Current practices, different models, ongoing clinical trials with EVLP and added therapeutics will be discussed. The attendee will increase his or her understanding of the technique, its applications and future directions. A 15-min panel discussion with all speakers will conclude this session.

    Refocusing the Blurry Vision: Biomarkers of Thoracic Allograft Rejection
    The goal of this symposium is to review advances in molecular diagnostic assessments and novel biomarkers in thoracic (both heart and lung) organ transplantation. This will include approaches that are being applied clinically and others that are investigational but that can provide greater insight into the pathophysiology and immunology of allograft rejection.

    Medical Management of LVAD Patients: Once the CHEST is Closed, the Trouble Begins
    This symposium will examine state of the art knowledge on device programming and medical management of LVAD patients. Current controversies such as the utility of platelet function monitoring and invasive hemodynamic testing will be reviewed and debated. A 10-min panel discussion with all speakers will conclude this session.

    Also, ISHLT members receive FREE access to 100s of online video recordings
    from past meetings and Academy Competency Courses. Learn more here.

    Note: Enroll in these courses only if you did not attend the corresponding session at ISHLT2019.

    For questions about the courses, contact, or visit for more information.